ITGA5 and Sepsis: To bridge these translational and mechanistic gaps, subsequent studies will focus on validating these findings in more complex, clinically relevant sepsis models (cecal ligation and puncture [CLP]), evaluating empagliflozin’s efficacy with therapeutic dosing regimens and serial echocardiographic assessments, and prioritizing the experimental validation of our computationally designed ITGA5 binders.